Body Protection Compound-157 (BPC-157) is arguably the most widely discussed research peptide in the longevity and performance space. Often referred to as the "Wolverine peptide" for its profound regenerative properties, it has gained immense popularity for treating soft tissue injuries, gut inflammation, and chronic pain.
This guide breaks down exactly how BPC-157 works, the clinical dosing protocols, and what the evidence actually says about its risks and benefits.
What Is BPC-157?
BPC-157 is a synthetic pentadecapeptide (a sequence of 15 amino acids) derived from a naturally occurring protective protein found in human gastric juice.
In the stomach, this parent protein protects the mucosal lining from acid and physical damage. When synthesized as BPC-157, it demonstrates remarkable systemic healing properties, extending far beyond the gastrointestinal tract to muscles, tendons, ligaments, and the nervous system.
How It Works: The Mechanism of Action
BPC-157 operates through a multi-pathway mechanism:
- Angiogenesis (New Blood Vessel Formation): BPC-157 strongly upregulates Vascular Endothelial Growth Factor (VEGF). By building new blood networks, it delivers oxygen and nutrients to tissues with poor blood supply (like tendons and ligaments), drastically speeding up repair.
- Growth Hormone Receptor Upregulation: It increases the density of growth hormone receptors on injured cells, making the body's natural growth hormone significantly more effective at the site of injury (PMID: 24893812).
- Collagen Synthesis: It directly stimulates fibroblasts, the cells responsible for producing collagen — the primary structural protein in tendons and ligaments.
- Nitric Oxide System Modulation: It protects the endothelium and regulates blood pressure during the healing process.
The Clinical Dosing Protocol
BPC-157 is highly systemic, meaning a subcutaneous injection in the abdomen will circulate and provide benefits throughout the body. However, many practitioners prefer local injections near the site of injury for acute trauma.
Standard Subcutaneous Dosage
| Phase | Daily Dose | Frequency | Cycle Length |
|---|---|---|---|
| Standard Recovery | 250mcg | Once daily | 4-6 weeks |
| Acute/Severe Injury | 500mcg | Once daily (or 250mcg twice daily) | 4-6 weeks |
| Maintenance | 250mcg | Every other day | As needed |
Note: BPC-157 has a short half-life (estimated 4-6 hours). For severe injuries, splitting the 500mcg dose into two 250mcg injections (morning and evening) maintains more stable blood levels.
Oral Dosage (Gut Healing)
Because BPC-157 is derived from gastric juice, it is highly stable in stomach acid. Oral administration is the preferred route for gastrointestinal issues (Leaky Gut, IBS, Crohn's, gastric ulcers).
- Standard Oral Dose: 500mcg taken once or twice daily on an empty stomach.
Benefits and Clinical Outcomes
1. Tendon and Ligament Repair
Tendons and ligaments heal notoriously slowly due to poor blood supply. BPC-157 has been shown to accelerate healing of Achilles tendon ruptures, MCL tears, and muscle crushes by promoting angiogenesis and collagen synthesis (PMID: 21861804).
2. Gastrointestinal Healing
As a gastric-derived peptide, BPC-157 excels at repairing the gut lining. It has demonstrated efficacy in healing gastric ulcers, reducing intestinal inflammation, and protecting the gut from NSAID damage.
3. Neuroprotection
Emerging research indicates BPC-157 protects the central nervous system. It modulates the dopaminergic and serotonergic systems, potentially aiding in recovery from traumatic brain injury (TBI) and reducing symptoms of depression and anxiety.
Real-World Side Effects
BPC-157 is generally well-tolerated, with a safety profile that currently appears superior to many traditional anti-inflammatory medications.
Common Side Effects
- Injection Site Reactions: Mild redness, itching, or swelling.
- Fatigue: Some users report lethargy during the first week.
- Headaches: Occasional, mild.
- Nausea: More common with oral administration.
The "Anhedonia" Phenomenon
A small subset of users report experiencing temporary anhedonia (reduced ability to feel pleasure) while taking BPC-157. This is theorized to be related to its modulation of the dopamine system. It typically resolves upon cessation.
Read our full BPC-157 compound profile → | Use the Dosage Calculator →